These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4751739)

  • 21. Late-onset pulmonary fibrosis and chest deformity in two children treated with cyclophosphamide.
    Alvarado CS; Boat TF; Newman AJ
    J Pediatr; 1978 Mar; 92(3):443-6. PubMed ID: 273085
    [No Abstract]   [Full Text] [Related]  

  • 22. [Drug induced pulmonary disease. Diffuse interstitial pneumonitis during chemoradiotherapy for small cell carcinoma of the lung. Two cases (author's transl)].
    Riou R; Duvillard P; Touraine R
    Poumon Coeur; 1982; 38(1):57-62. PubMed ID: 6283505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous cyclophosphamide and methylprednisolone for the treatment of bronchiolitis obliterans and interstitial fibrosis associated with crysotherapy.
    Fort JG; Scovern H; Abruzzo JL
    J Rheumatol; 1988; 15(5):850-4. PubMed ID: 3172099
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemotherapy-related delayed bilateral spontaneous pneumothorax and lung fibrosis: methotrexate or cyclophosphamide, or both?
    Fang L; Huang CJ; Chuang AY; Tan TD; Liu CC
    Clin Respir J; 2010 Oct; 4(4):254-5. PubMed ID: 20931743
    [No Abstract]   [Full Text] [Related]  

  • 25. The molecular basis of interstitial pulmonary fibrosis caused by antineoplastic agents.
    Lazo JS; Hoyt DG
    Cancer Treat Rev; 1990 Sep; 17(2-3):165-7. PubMed ID: 1703044
    [No Abstract]   [Full Text] [Related]  

  • 26. The toxicity of busulphan and cyclophosphamide as the preparative regimen for bone marrow transplantation.
    Morgan M; Dodds A; Atkinson K; Szer J; Downs K; Biggs J
    Br J Haematol; 1991 Apr; 77(4):529-34. PubMed ID: 2025579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclophosphamide in diffuse lung damage.
    Musiatowicz B; Sulkowska M; Sulik M; Famulski W; Dziecioł J; Sobaniec-Lotowska M; Baltaziak M; Arciuch L; Rółkowski R; Jabłońska E
    Rocz Akad Med Bialymst; 1997; 42 Suppl 2():73-8. PubMed ID: 9646685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 12-1978.
    N Engl J Med; 1978 Mar; 298(13):729-36. PubMed ID: 628398
    [No Abstract]   [Full Text] [Related]  

  • 29. [Analysis of alveolitis (pneumonitis) as a complication of cytostatic (CMF) therapy].
    Tallósy I; Vargha G; Pölöskey A; Nagy Z; Kricskovits A
    Orv Hetil; 1987 Aug; 128(31):1621-2. PubMed ID: 3614922
    [No Abstract]   [Full Text] [Related]  

  • 30. Pulmonary, pleural and thoracic changes complicating chemotherapy.
    Tucker AS; Newman AJ; Alvorado C
    Radiology; 1977 Dec; 125(3):805-9. PubMed ID: 928714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclophosphamide-induced late-onset lung disease.
    Hamada K; Nagai S; Kitaichi M; Jin G; Shigematsu M; Nagao T; Sato A; Mishima M
    Intern Med; 2003 Jan; 42(1):82-7. PubMed ID: 12583625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lung toxicity associated with cyclophosphamide use. Two distinct patterns.
    Malik SW; Myers JL; DeRemee RA; Specks U
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1851-6. PubMed ID: 8970380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclophosphamide in the treatment of idiopathic pulmonary fibrosis: a prospective study in patients who failed to respond to corticosteroids.
    Zisman DA; Lynch JP; Toews GB; Kazerooni EA; Flint A; Martinez FJ
    Chest; 2000 Jun; 117(6):1619-26. PubMed ID: 10858393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulmonary effects of cytotoxic agents other than bleomycin.
    Twohig KJ; Matthay RA
    Clin Chest Med; 1990 Mar; 11(1):31-54. PubMed ID: 1691069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Interstitial pneumonia after CMC (CDDP, MMC, CPM) therapy].
    Sagawa M; Takahashi S; Usuda K; Kamma K; Satoh M; Ohta S; Nagamoto N; Imai T; Saitoh Y; Suda H
    Gan No Rinsho; 1988 Feb; 34(2):150-4. PubMed ID: 3126331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 8-1982. Diffuse pulmonary infiltrates in a patient with lymphoma.
    N Engl J Med; 1982 Feb; 306(8):469-76. PubMed ID: 6276747
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinicopathological conference. Two cases of drug-induced disease. Demonstration at the Royal College of Physicians of London.
    Br Med J; 1978 Nov; 2(6149):1405-10. PubMed ID: 102404
    [No Abstract]   [Full Text] [Related]  

  • 38. Interstitial pulmonary disease induced by occupational exposure to paraffin.
    Pujol JL; Barnéon G; Bousquet J; Michel FB; Godard P
    Chest; 1990 Jan; 97(1):234-6. PubMed ID: 2295245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary fibrosis following low-dose 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) therapy.
    Melato M; Tuveri G
    Cancer; 1980 Mar; 45(6):1311-4. PubMed ID: 7357522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary toxicity of cyclophosphamide: a 1-year study.
    Morse CC; Sigler C; Lock S; Hakkinen PJ; Haschek WM; Witschi HP
    Exp Mol Pathol; 1985 Apr; 42(2):251-60. PubMed ID: 3979520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.